São Paulo - Delayed Quote BRL
Regeneron Pharmaceuticals, Inc. (REGN34.SA)
56.05
+0.33
+(0.59%)
As of 10:48:56 AM GMT-3. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 19 | 16 | 25 | 22 |
| Avg. Estimate | 3.26B | 3.49B | 14.25B | 15.15B |
| Low Estimate | 2.94B | 3.21B | 13.1B | 13.23B |
| High Estimate | 3.72B | 3.86B | 15.69B | 18.07B |
| Year Ago Sales | 3.15B | 3.55B | 14.2B | 14.25B |
| Sales Growth (year/est) | 3.76% | -1.52% | 0.31% | 6.33% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| REGN34.SA | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Related Tickers
7RG0.F Regulus Therapeutics Inc.
2.2800
+12.87%
AXD2.F Heron Therapeutics, Inc.
1.9010
+1.39%
HTD.SG Corcept Therapeutics Inc
62.34
+0.94%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
IM8N.F Insmed Incorporated
59.00
-7.81%
BVNRY Bavarian Nordic A/S
7.72
0.00%
SNGX Soligenix, Inc.
2.1309
+2.94%
XFOR X4 Pharmaceuticals, Inc.
0.1844
-8.40%
MREO Mereo BioPharma Group plc
2.5152
-1.75%
XERS Xeris Biopharma Holdings, Inc.
4.3081
+4.31%